Report Detail

Table of Contents

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 Alpha-blocker
        • 1.1.2.2 Phosphodiesterase Type-5 Inhibitors
        • 1.1.2.3 5-alpha-Reductase Inhibitors
      • 1.1.3 Market by Application
        • 1.1.3.1 Hospitals
        • 1.1.3.2 Clinics
        • 1.1.3.3 Others
    • 1.2 Global and Regional Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and Regional Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and Regional Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and Regional Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 Regional Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Astellas Pharma
      • 6.1.2 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Eli Lilly
      • 6.2.1 Company Information
      • 6.2.2 Product Specifications
      • 6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.3 GlaxoSmithKline
      • 6.3.1 Company Information
      • 6.3.2 Product Specifications
      • 6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.4 Sanofi
      • 6.4.1 Company Information
      • 6.4.2 Product Specifications
      • 6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.5 ADC Therapeutics
      • 6.5.1 Company Information
      • 6.5.2 Product Specifications
      • 6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.6 Bayer HealthCare
      • 6.6.1 Company Information
      • 6.6.2 Product Specifications
      • 6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.7 Bristol-Myers Squibb
      • 6.7.1 Company Information
      • 6.7.2 Product Specifications
      • 6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.8 Valeant Pharmaceuticals
      • 6.8.1 Company Information
      • 6.8.2 Product Specifications
      • 6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.9 Endo Pharmaceuticals
      • 6.9.1 Company Information
      • 6.9.2 Product Specifications
      • 6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.10 Foresee Pharmaceuticals
      • 6.10.1 Company Information
      • 6.10.2 Product Specifications
      • 6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.11 Madrigal Pharmaceuticals
    • 6.12 Merck
    • 6.13 Novartis
    • 6.14 Spectrum Pharmaceuticals
    • 6.15 Takeda Pharmaceuticals
    • 6.16 Teva
    • 6.17 Advaxis
    • 6.18 ANI Pharmaceuticals
    • 6.19 BHR Pharma

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary
    Market Segment as follows:
    By Type
    Alpha-blocker
    Phosphodiesterase Type-5 Inhibitors
    5-alpha-Reductase Inhibitors
    By Application
    Hospitals
    Clinics
    Others
    By Company
    Astellas Pharma
    Eli Lilly
    GlaxoSmithKline
    Sanofi
    ADC Therapeutics
    Bayer HealthCare
    Bristol-Myers Squibb
    Valeant Pharmaceuticals
    Endo Pharmaceuticals
    Foresee Pharmaceuticals
    Madrigal Pharmaceuticals
    Merck
    Novartis
    Spectrum Pharmaceuticals
    Takeda Pharmaceuticals
    Teva
    Advaxis
    ANI Pharmaceuticals
    BHR Pharma
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.


    Summary:
    Get latest Market Research Reports on Benign Prostatic Hyperplasia (BPH) Drugs. Industry analysis & Market Report on Benign Prostatic Hyperplasia (BPH) Drugs is a syndicated market report, published as Global and China Benign Prostatic Hyperplasia (BPH) Drugs Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Benign Prostatic Hyperplasia (BPH) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,000.00
    $3,000.00
    $4,000.00
    1,464.01
    2,196.01
    2,928.02
    1,650.33
    2,475.50
    3,300.66
    207,544.00
    311,316.00
    415,088.00
    146,088.20
    219,132.30
    292,176.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report